Grape King Bio Ltd
TAI: 1707.TW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taiwan Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Sheng-Lin Tseng
- Employees
- 501
- Headquarters
- Taoyuan City, Taiwan
- IPO year
- 2000
- Market cap
- NT$16.7B
- Website
- https://www.grapeking.com.tw
Loading 1707…
Loading profile data…Frequently asked questions about 1707
What does Grape King Bio Ltd (1707.TW) do?
Grape King Bio Ltd produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy foods in Taiwan, China, and internationally. It operates through Multi-Level Marketing, Distributors, and Original Design Manufacturer/Original Equipment Manufacturer (ODM/OEM) segments. The company offers mushroom mycelium pro...
Where does 1707.TW trade?
Grape King Bio Ltd (1707.TW) trades on the Taiwan Stock Exchange.
What sector is 1707.TW in?
Grape King Bio Ltd (1707.TW) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Grape King Bio Ltd?
Sheng-Lin Tseng is the chief executive officer of Grape King Bio Ltd (1707.TW).
Where is Grape King Bio Ltd headquartered?
Grape King Bio Ltd is headquartered in Taiwan.
Does 1707.TW pay a dividend?
Yes — Grape King Bio Ltd (1707.TW) paid a trailing twelve-month dividend of TWD 6.40 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 1707.TW go public?
Grape King Bio Ltd (1707.TW) completed its initial public offering in 2000.